(IN BRIEF) Equinor (OSE: EQNR, NYSE: EQNR) announces its proposed cash dividends for the fourth quarter of 2023. Shareholders can expect an ordinary cash dividend of USD 0.35 per share, along with an additional extraordinary cash dividend of USD 0.35 … Read the full press release
(PRESSEMITTEILUNG) STAVANGER, 18-Feb-2022 — /EuropaWire/ — Equinor ASA (OSE:EQNR, NYSE:EQNR), ein Öl- und Gasunternehmen , ein Wind- und Solarenergieunternehmen, das in mehr als 30 Märkten weltweit tätig ist, hat am 27. Oktober 2021 eine Dividende pro Aktie von 0,18 USD … Read the full press release
(PRESS RELEASE) STAVANGER, 18-Feb-2022 — /EuropaWire/ — Equinor ASA (OSE:EQNR, NYSE:EQNR), an oil, gas, wind and solar energy company active in more than 30 markets globally, has announced on 27 October 2021 a dividend per share of USD 0.18 for … Read the full press release
(PRESS RELEASE) STAVANGER, 17-Jan-2022 — /EuropaWire/ — Equinor ASA (OSE:EQNR, NYSE:EQNR), an oil, gas, wind and solar energy company active in more than 30 markets globally, has announced that DNB, Norway’s largest financial services group, has purchased 439,542 shares on … Read the full press release
Posted in Energy, Gas & Oil, Financial, Industrial, Investment, News, Norway
Tagged DNB, Equinor, Norwegian Securities Trading Act, shares
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
